Susan Peszko Isolyser Company, Inc. The new product, LTS-Plus, has met the rigorous standards for registration under the EPA guidelines for medical waste treatment products.
Final approval is pending submission of final product labeling.
These products are well known in hospitals for protecting the staff from the hazards of handling infectious liquids, while maintaining a balance with environmental responsibility. LTS-PLUS will be manufactured and sold by Microtek Medical, Inc., a subsidiary of Isolyser. We have hundreds of loyal customers that have been waiting for this product to clear the regulatory process and we are happy to have the opportunity to introduce LTS-PLUS to them in the near future. Timing of product availability will follow the completion of individual state regulatory requirements. Several of these state approvals are already in hand.